On December 31, 2018 Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), reported that Management will meet Investors and potential partners at the 2019 China Focus event, and during the 37th Annual J.P. Morgan Healthcare Conference in San Francisco (Press release, Onconova, DEC 31, 2018, View Source [SID1234532311]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

China Focus@JPM Week Sunday, January 6th
JW Marriott 515 Mason St, 2nd Floor 8:00a-7:00p

J.P. Morgan Conference Monday, January 7th – Thursday, January 10th

Meetings can be scheduled by contacting Suzanne Hutchison ([email protected]).